BES has recently completed the modernisation of the new Protein Science Laboratories for AstraZeneca, within their facility at Granta Park in Cambridge.

As part of AstraZeneca’s UK strategic goal, scientists have moved from the existing Alderley Park research and development laboratories in Cheshire to this new facility, which has been put to immediate use in supporting efforts to develop a vaccine for COVID-19.

Working as principal designer and principal contractor, our multidisciplinary team reconfigured the existing space to accommodate the new Protein Science laboratories and Cold-room.  BES carried out a fully detailed design to RIBA Stage 4 and progressed straight through to construction on a full turnkey basis.  Adopting a collaborative culture from the outset, we effectively drove the schedule and ensured all construction and commissioning activities were completed within a challenging four month programme.

Dan Mason, Capital Portfolio Lead at AstraZeneca comments, ‘Following a successful completion, the facility is now operational and fully compliant with SHE requirements. The programme involved a demanding timescale that was achieved due to the collaboration and hard work by all those involved, including AstraZeneca employees, BES team, our service providers, partners and supply chain, all of whom have demonstrated a commitment to the highest of standards throughout.’ 

We are very proud to have played our part in this important project, and we’d like to say thank you to all involved and congratulations on this fantastic achievement.  

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, CVRM and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.